| 2022 | A multi-institutional, single-arm, phase II trial of neoadjuvant modified-FOLFIRINOX for resectable pancreatic ductal adenocarcinoma | JOURNAL OF CLINICAL ONCOLOGY |
| 2011 | A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results. | LUNG CANCER |
| 2014 | A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma. | CLINICAL CANCER RESEARCH |
| 2005 | A Pilot Study of Trans-Arterial Injection of 166Holmium-Chitosan Complex for Treatment of Small Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
| 2008 | A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features | ONCOLOGY REPORTS |
| 2022 | Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways
| BMC CANCER |
| 2009 | Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma. | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2021 | Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2019 | An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma
| Oncologist |
| 2023 | ARID1A Mutation from Targeted NGS Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer
| CANCER RESEARCH AND TREATMENT |
| 2010 | Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: a phase II trial | LUNG CANCER |
| 2013 | Better Outcome of XELOX Chemotherapy in Patients with Advanced Intestinal-Type Adenocarcinoma of the Ampulla of Vater
| TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE |
| 2009 | Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC | JOURNAL OF NEURO-ONCOLOGY |
| 2008 | Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer. | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2019 | Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial | ANNALS OF ONCOLOGY |
| 2007 | Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapy | ACTA ONCOLOGICA |
| 2016 | Characteristics of Venous Thromboembolism in Pancreatic Adenocarcinoma in East Asian Ethnics: A Large Population-Based Observational Study
| MEDICINE |
| 2008 | Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy. | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2009 | Complete response of recurrent squamous cell carcinoma of the lung: dose the dose matter? | JOURNAL OF THORACIC ONCOLOGY |
| 2004 | Congenital absence of inferior vena cava as a rare cause of pulmonary thromboembolism
| YONSEI MEDICAL JOURNAL |
| 2019 | Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
| Cancer Medicine |
| 2019 | Distinct immunological properties of the two histological subtypes of adenocarcinoma of the ampulla of Vater | CANCER IMMUNOLOGY IMMUNOTHERAPY |
| 2009 | Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect | GENE THERAPY |
| 2017 | Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib.
| YONSEI MEDICAL JOURNAL |
| 2021 | Early Diagnostic Ability of Human Complement Factor B in Pancreatic Cancer Is Partly Linked to Its Potential Tumor-Promoting Role | JOURNAL OF PROTEOME RESEARCH |
| 2020 | Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine (a CYP1A2 Substrate) in Patients With BRAF V600 Mutation-Positive Malignancies | CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT |
| 2020 | Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| 2021 | Enhanced oncolytic adenoviral production by downregulation of death-domain associated protein and overexpression of precursor terminal protein
| SCIENTIFIC REPORTS |
| 2022 | Enhanced tumor targeting and timely viral release of mesenchymal stem cells/oncolytic virus complex due to GRP78 and inducible E1B55K expressions greatly increase the antitumor effect of systemic treatment
| MOLECULAR THERAPY-ONCOLYTICS |
| 2011 | Evaluation of Bone Metastasis from Hepatocellular Carcinoma Using 18F-FDG PET/CTand 99mTc-HDP Bone Scintigraphy: Characteristics of Soft Tissue Formation.
| NUCLEAR MEDICINE AND MOLECULAR IMAGING |
| 2021 | Expression of Organic Anion Transporting Polypeptides in an H-Ras 12V Transgenic Mouse Model of Spontaneous Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
| 2020 | Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma
| SCIENTIFIC REPORTS |
| 2015 | ¹⁸F-FDG PET/CT in hepatocellular carcinoma: detection of bone metastasis and prediction of prognosis | NUCLEAR MEDICINE COMMUNICATIONS |
| 2010 | Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer.
| CANCER |
| 2012 | Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study. | LANCET ONCOLOGY |
| 2015 | Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2014 | Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma. | JOURNAL OF NEURO-ONCOLOGY |
| 2019 | High levels of Daxx due to low cellular levels of HSP25 in murine cancer cells result in inefficient adenovirus replication
| EXPERIMENTAL AND MOLECULAR MEDICINE |
| 2009 | High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer.
| CLINICAL CANCER RESEARCH |
| 2020 | Human Organic Anion Transporting Polypeptide 1B3 Applied as an MRI-Based Reporter Gene
| KOREAN JOURNAL OF RADIOLOGY |
| 2021 | Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma | JOURNAL OF HEPATOLOGY |
| 2012 | In vitro adenosine triphosphate-based chemotherapy response assay (ATP-CRA) in solid pseudopapillary tumor of the pancreas | PANCREAS |
| 2024 | Inhibition of the Alternative Complement Pathway May Cause Secretion of Factor B, Enabling an Early Detection of Pancreatic Cancer | JOURNAL OF PROTEOME RESEARCH |
| 2019 | Interprofessional Collaboration Between a Multidisciplinary Palliative Care Team and the Team Pharmacist on Pain Management | AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE |
| 2020 | Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study
| CANCER SCIENCE |
| 2021 | Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG)
| ESMO OPEN |
| 2011 | Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma. | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2017 | Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis.
| MEDICINE |
| 2011 | MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation
| ONCOLOGY REPORTS |
| 2019 | Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer | ONCOLOGIST |
| 2021 | Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death-Ligand 1 Blockade Responses | HEPATOLOGY |
| 2015 | Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer | TRANSLATIONAL ONCOLOGY |
| 2018 | Multiple systemic extraneural metastasis of glioblastoma | CHIRURGIA |
| 2023 | Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial
| ECLINICALMEDICINE |
| 2010 | Outcome of adjuvant therapy for gallbladder cancer | ONCOLOGY |
| 2023 | Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea
| PALLIATIVE MEDICINE REPORTS |
| 2018 | Outpatient Palliative Care and Aggressiveness of End-of-Life Care in Patients with Metastatic Colorectal Cancer | AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE |
| 2010 | Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2015 | Pain palliation in patients with bone metastases using magnetic resonance-guided focused ultrasound with conformal bone system: a preliminary report.
| YONSEI MEDICAL JOURNAL |
| 2021 | Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations
| INVESTIGATIONAL NEW DRUGS |
